This announcement is a separate document:
English
Back
- Markets
- Features
- News
- Community
- Learn
- Help Center
- About
- Offers & Rewards
- Welcome RewardsOpen an account and get up to HKD1800!
- Enjoy limited-time 5%+5% returns on Cash PlusInvest any amount and enjoy a 5% average return on Cash Plus + 5% welcome reward
- Join Futubull Membership ProgramUnlock 11 Premier Benefits
- Referral PromotionBring a friend and collect up to HK$600 in rewards
- Learn PremiumAnalyst 1V1 online teaching
- Stock TransferSwitch to Futu and get up to HK$7,000 in rewards
- English
- 繁體中文
- 简体中文
- Dark
- Light
Papyrus Australia Ltd: Annual Report to shareholders 2021
Nov 1, 2021 08:42
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
03:48
Hezbollah's statement: The occupation of more Syrian territory by Israel and the destruction of its military capabilities is a dangerous act of aggression. The United Nations Security Council, the international community, as well as Arab and Islamic countries have the responsibility to reject and put an end to such actions, and to protect them during this sensitive and critical phase in Syria's history.
03:44
Ferrari CEO: Does not believe that demand will change after the Trump administration takes office, and is preparing just in case.
RACE+0.52%
03:42
The National Institutes of Health (NIH) in the USA found that Tecovrimat is safe, but not an effective solution for improving symptoms in monkeypox patients.